Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (5): 400-408.doi: 10.35541/cjd.20230603
• Guidelines and Consensus • Previous Articles Next Articles
Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement (2024)”
Received:
2023-10-23
Revised:
2024-01-18
Online:
2024-05-15
Published:
2024-04-30
Contact:
Chen Xiang; Shang Guanning; Chen Rongyi
E-mail:chenxiangck@126.com;shgn1975@163.com;rongyichen@163.com
Supported by:
Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement ()”. Treatment of extramammary Paget′s disease: a Chinese expert consensus statement (2024)[J]. Chinese Journal of Dermatology, 2024, 57(5): 400-408.doi:10.35541/cjd.20230603
[1] | Elder DE, Massi D, Scolyer RA, et al. WHO classification of skin tumours[M]. 4th ed. Lyon: IARC Press, 2018. |
[2] | Yin S, Xu L, Wang S, et al. Prevalence of extramammary Paget′s disease in urban China: a population⁃based study[J]. Orphanet J Rare Dis, 2021,16(1):134. doi: 10.1186/s13023⁃021⁃01715⁃6. |
[3] | van der Zwan JM, Siesling S, Blokx WA, et al. Invasive extramammary Paget′s disease and the risk for secondary tumours in Europe[J]. Eur J Surg Oncol, 2012,38(3):214⁃221. doi: 10.1016/j.ejso.2011.12.008. |
[4] | Ghazawi FM, Iga N, Tanaka R, et al. Demographic and clinical characteristics of extramammary Paget′s disease patients in Japan from 2000 to 2019[J]. J Eur Acad Dermatol Venereol, 2021,35(2):e133⁃e135. doi: 10.1111/jdv.16868. |
[5] | OCEBM Levels of Evidence Working Group. “The Oxford Levels of Evidence 2”. Oxford Centre for Evidence⁃Based Medicine[EB/OL]. 2011. https://www.cebm.ox.ac.uk/resources/levels⁃of⁃evidence/ocebm⁃levels⁃of⁃evidence. |
[6] | Regauer S. Extramammary Paget′s disease — a proliferation of adnexal origin?[J]. Histopathology, 2006,48(6):723⁃729. doi: 10.1111/j.1365⁃2559.2006.02405.x. |
[7] | Zhang G, Zhou S, Zhong W, et al. Whole⁃exome sequencing reveals frequent mutations in chromatin remodeling genes in mammary and extramammary Paget′s diseases[J]. J Invest Dermatol, 2019,139(4):789⁃795. doi: 10.1016/j.jid.2018.08.030. |
[8] | Kajtezovic S, Walker AR, Hjalmarsson B, et al. Management of secondary Paget′s disease of the vulva associated with transitional cell carcinoma[J]. J Cancer Res Clin Oncol, 2022,148(7):1697⁃1702. doi: 10.1007/s00432⁃022⁃04007⁃z. |
[9] | Lam C, Funaro D. Extramammary Paget′s disease: summary of current knowledge[J]. Dermatol Clin, 2010,28(4):807⁃826. doi: 10.1016/j.det.2010.08.002. |
[10] | 王光平, 李燕, 王惠平, 等. 硬化萎缩性苔藓样乳房外Paget病1例[J]. 中华皮肤科杂志, 2023,56(4):346⁃347. doi: 10.35541/cjd.20201233. |
[11] | Ishizuki S, Nakamura Y. Extramammary Paget′s disease: diagnosis, pathogenesis, and treatment with focus on recent developments[J]. Curr Oncol, 2021,28(4):2969⁃2986. doi: 10. 3390/curroncol28040260. |
[12] | Morris CR, Hurst EA. Extramammary Paget disease: a review of the literature⁃part i: history, epidemiology, pathogenesis, presentation, histopathology, and diagnostic work⁃up[J]. Dermatol Surg, 2020,46(2):151⁃158. doi: 10.1097/DSS.0000000000002064. |
[13] | Simonds RM, Segal RJ, Sharma A. Extramammary Paget′s disease: a review of the literature[J]. Int J Dermatol, 2019,58(8):871⁃879. doi: 10.1111/ijd.14328. |
[14] | Ito T, Kaku⁃Ito Y, Furue M. The diagnosis and management of extramammary Paget′s disease[J]. Expert Rev Anticancer Ther, 2018,18(6):543⁃553. doi: 10.1080/14737140.2018.1457955. |
[15] | Cho WC, Ding Q, Wang WL, et al. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics[J]. J Cutan Pathol, 2023,50(5):434⁃440. doi: 10.1111/cup.14414. |
[16] | Taniguchi K, Goto K, Yabushita H, et al. Transcriptional repressor GATA binding 1 (TRPS1) immunoexpression in normal skin tissues and various cutaneous tumors[J]. J Cutan Pathol, 2023,50(11):1006⁃1013. doi: 10.1111/cup.14523. |
[17] | Liu YA, Collins K, Aung PP, et al. TRPS1 expression in primary and secondary extramammary Paget diseases: an immunohisto⁃chemical analysis of 93 cases[J]. Hum Pathol, 2024,143:5⁃9. doi: 10.1016/j.humpath.2023.11.004. |
[18] | Nakamura Y, Tanese K, Hirai I, et al. Serum cytokeratin 19 fragment 21⁃1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease[J]. Br J Dermatol, 2019,181(3):535⁃543. doi: 10.1111/bjd.17789. |
[19] | Kato J, Sumikawa Y, Hida T, et al. Serum cytokeratin 19 fragment 21⁃1 is a useful tumor marker for the assessment of extramammary Paget′s disease[J]. J Dermatol, 2017,44(6):666⁃670. doi: 10.1111/1346⁃8138.13760. |
[20] | Mijiddorj T, Kajihara I, Tasaki Y, et al. Serum cell⁃free DNA levels are a useful marker for extramammary Paget disease[J]. Br J Dermatol, 2019,181(3):505⁃511. doi: 10.1111/bjd.17709. |
[21] | Schmitt AR, Long BJ, Weaver AL, et al. Evidence⁃based screening recommendations for occult cancers in the setting of newly diagnosed extramammary Paget disease[J]. Mayo Clin Proc, 2018,93(7):877⁃883. doi: 10.1016/j.mayocp.2018.02.024. |
[22] | 张韡, 黄莉明, 聂瑾, 等. 皮肤镜在外阴部乳房外Paget病与慢性湿疹鉴别诊断中的意义[J]. 中华皮肤科杂志, 2019,52(9):636⁃639. doi: 10.3760/cma.j.issn.0412⁃4030.2019.09.009. |
[23] | Bayan CY, Khanna T, Rotemberg V, et al. A review of non⁃invasive imaging in extramammary Paget′s disease[J]. J Eur Acad Dermatol Venereol, 2018,32(11):1862⁃1873. doi: 10.1111/ jdv.15072. |
[24] | Komatsu⁃Fujii T, Nomura T, Kaku Y, et al. In vivo identification of tumor cells of the basal layer of the epidermis in an early lesion of extramammary Paget disease: a reflectance confocal microscopic analysis[J]. JAAD Case Rep, 2021,11:12. doi: 10.1016/j.jdcr.2021.02.026. |
[25] | 国家皮肤与免疫疾病临床医学研究中心, 中国医师协会皮肤科医师分会皮肤外科亚专业委员会, 中国中西医结合学会皮肤性病学专业委员会皮肤影像学组, 等. 常见皮肤病高频皮肤超声诊断专家共识[J]. 中国医学前沿杂志(电子版), 2019,11(8):23⁃28. doi: 10.12037/YXQY.2019.08⁃04. |
[26] | Okumura M, Ogata D, Namikawa K, et al. Postoperative radiation therapy improves prognoses in extramammary Paget′s disease presenting with multiple lymph node metastases[J]. J Dermatol, 2022,49(10):1005⁃1011. doi: 10.1111/1346⁃8138. 16491. |
[27] | Ogata D, Kiyohara Y, Yoshikawa S, et al. Usefulness of sentinel lymph node biopsy for prognostic prediction in extramammary Paget′s disease[J]. Eur J Dermatol, 2016,26(3):254⁃259. doi: 10.1684/ejd.2016.2744. |
[28] | Ohara K, Fujisawa Y, Yoshino K, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors[J]. J Dermatol Sci, 2016,83(3):2349. doi: 10.1016/j.jdermsci.2016. 06.004. |
[29] | Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual[M]. 8th ed. New York, NY: Springer, 2017. |
[30] | Nasioudis D, Bhadra M, Ko EM. Extramammary Paget disease of the vulva: management and prognosis[J]. Gynecol Oncol, 2020,157(1):146⁃150. doi: 10.1016/j.ygyno.2019.11.009. |
[31] | Hatta N, Yamada M, Hirano T, et al. Extramammary Paget′s disease: treatment, prognostic factors and outcome in 76 patients[J]. Br J Dermatol, 2008,158(2):313⁃318. doi: 10.1111/j.1365⁃2133.2007.08314.x. |
[32] | Kibbi N, Owen JL, Worley B, et al. Evidence⁃based clinical practice guidelines for extramammary Paget disease[J]. JAMA Oncol, 2022,8(4):618⁃628. doi: 10.1001/jamaoncol.2021.7148. |
[33] | Kaku⁃Ito Y, Ito T, Tsuji G, et al. Evaluation of mapping biopsies for extramammary Paget disease: a retrospective study[J]. J Am Acad Dermatol, 2018,78(6):1171⁃1177.e4. doi: 10.1016/j.jaad.2017.12.040. |
[34] | Kato T, Fujimoto N, Fujii N, et al. Mapping biopsy with punch biopsies to determine surgical margin in extramammary Paget′s disease[J]. J Dermatol, 2013,40(12):968⁃972. doi: 10.1111/1346⁃8138.12347. |
[35] | Kim GY, Campbell EH, Brewer JD. Local recurrence rates of extramammary Paget disease are lower after Mohs micrographic surgery compared with wide local excision: a systematic review and meta⁃analysis[J]. Dermatol Surg, 2023,49(1):8⁃12. doi: 10.1097/DSS.0000000000003601. |
[36] | Bae JM, Choi YY, Kim H, et al. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data[J]. J Am Acad Dermatol, 2013,68(4):632⁃637. doi: 10.1016/j.jaad.2012.12.960. |
[37] | Long B, Schmitt AR, Weaver AL, et al. A matter of margins: surgical and pathologic risk factors for recurrence in extramammary Paget′s disease[J]. Gynecol Oncol, 2017,147(2):358⁃363. doi: 10.1016/j.ygyno.2017.09.008. |
[38] | 万苗坚, 马寒, 龚子鉴, 等. 周围组织的 Mohs 显微描记外科手术治疗乳房外Paget病[J]. 中华皮肤科杂志, 2016,49(4):278⁃280. doi: 10.3760/cma.j.issn.0412⁃4030.2016.04.012. |
[39] | 孔令卓, 张韡, 单士军, 等. 反射式共聚焦显微镜辅助手术治疗外阴乳房外Paget病二例[J]. 中华皮肤科杂志, 2021,54(8):723⁃725. doi: 10.35541/cjd.20180711. |
[40] | Wu M, Huang L, Lu X, et al. Utility of photodynamic diagnosis plus reflectance confocal microscopy in detecting the margins of extramammary Paget disease[J]. Indian J Dermatol Venereol Leprol, 2021,87(2):207⁃213. doi: 10.25259/IJDVL_90_20. |
[41] | Navarrete⁃Dechent C, Aleissa S, Cordova M, et al. Treatment of extramammary Paget disease and the role of reflectance confocal microscopy: a prospective study[J]. Dermatol Surg, 2021,47(4):473⁃479. doi: 10.1097/DSS.0000000000002934. |
[42] | Dengel L, Turza K, Noland MM, et al. Skin mapping with punch biopsies for defining margins in melanoma: when you don′t know how far to go[J]. Ann Surg Oncol, 2008,15(11):3028⁃3035. doi: 10.1245/s10434⁃008⁃0138⁃1. |
[43] | Huang SW, Wang ST, Chang SH, et al. Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2⁃deoxyglucose[J]. J Invest Dermatol, 2020,140(9):1771⁃1783.e6. doi: 10.1016/j.jid.2019. 12.039. |
[44] | van der Linden M, van Hees CL, van Beurden M, et al. The Paget trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease[J]. Am J Obstet Gynecol, 2022,227(2):250.e1⁃250.e8. doi: 10.1016/j.ajog.2022.04.012. |
[45] | Snast I, Sharon E, Kaftory R, et al. Nonsurgical treatments for extramammary Paget disease: a systematic review and meta⁃analysis[J]. Dermatology, 2020,236(6):493⁃499. doi: 10.1159/000506832. |
[46] | Machida H, Moeini A, Roman LD, et al. Effects of imiquimod on vulvar Paget′s disease: a systematic review of literature[J]. Gynecol Oncol, 2015,139(1):165⁃171. doi: 10.1016/j.ygyno.2015. 07.097. |
[47] | Donohoe C, Senge MO, Arnaut LG, et al. Cell death in photodynamic therapy: from oxidative stress to anti⁃tumor immunity[J]. Biochim Biophys Acta Rev Cancer, 2019,1872(2):188308. doi: 10.1016/j.bbcan.2019.07.003. |
[48] | Gao Y, Zhang XC, Wang WS, et al. Efficacy and safety of topical ALA⁃PDT in the treatment of EMPD[J]. Photodiagnosis Photodyn Ther, 2015,12(1):92⁃97. doi: 10.1016/j.pdpdt.2014.11.004. |
[49] | 张良, 陈娜, 郑亮, 等. Mohs显微手术治疗乳房外Paget病42例[J]. 中国麻风皮肤病杂志, 2017,33(7):410⁃412. |
[50] | 叶文正, 李词娟, 吴一文, 等. Mohs手术联合光动力治疗乳房外Paget病的临床观察[J]. 中国美容医学, 2018,27(6):4⁃7. |
[51] | 王奕, 胡利萍, 廖程琦, 等. Mohs手术与光动力疗法单独或联合应用治疗乳房外Paget病疗效观察[J]. 中国美容医学, 2020,29(10):61⁃64. |
[52] | 张慧, 李光, 聂敏艳, 等. 荧光定位肿瘤边界并手术ALA⁃PDT治愈乳房外Paget病1例[J]. 中国医学文摘(皮肤科学), 2015,32(2):228⁃231. |
[53] | 杨镓宁, 潘宁, 戴耕武, 等. Mohs显微描记手术联合光动力疗法治疗会阴部乳房外Paget病1例[J]. 实用皮肤病学杂志, 2013,6(1):31⁃33. doi: 10.11786/sypfbxzz.1674⁃1293.20130113. |
[54] | Shim PJ, Zeitouni NC. Photodynamic therapy for extramammary Paget′s disease: a systematic review of the literature[J]. Photodiagnosis Photodyn Ther, 2020,31:101911. doi: 10.1016/j.pdpdt.2020.101911. |
[55] | Tolia M, Tsoukalas N, Sofoudis C, et al. Primary extramammary invasive Paget′s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?[J]. BMC Cancer, 2016,16:563. doi: 10.1186/s12885⁃016⁃2622⁃5. |
[56] | Hata M, Koike I, Wada H, et al. Postoperative radiation therapy for extramammary Paget′s disease[J]. Br J Dermatol, 2015,172(4):1014⁃1020. doi: 10.1111/bjd.13357. |
[57] | Tagliaferri L, Casà C, Macchia G, et al. The role of radiotherapy in extramammary Paget disease: a systematic review[J]. Int J Gynecol Cancer, 2018,28(4):829⁃839. doi: 10.1097/IGC.00000 00000001237. |
[58] | Itonaga T, Nakayama H, Okubo M, et al. Radiotherapy in patients with extramammary Paget′s disease — our own experience and review of the literature[J]. Oncol Res Treat, 2014,37(1⁃2):18⁃22. doi: 10.1159/000358161. |
[59] | Hata M, Koike I, Wada H, et al. Radiation therapy for extramammary Paget′s disease: treatment outcomes and prognostic factors[J]. Ann Oncol, 2014,25(1):291⁃297. doi: 10.1093/annonc/mdt478. |
[60] | Molina GE, Khalifian S, Mull JL, et al. Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary Paget disease[J]. JAMA Dermatol, 2019,155(5):599603. doi: 10.1001/jamadermatol.2018.4793. |
[61] | Ferrara F, Bardazzi F, Messori S, et al. Photodynamic therapy following fractional CO2 laser for treatment of primary vulvar Paget′s disease: does it really work?[J]. J Dermatolog Treat, 2021,32(7):800⁃802. doi: 10.1080/09546634.2019.1707755. |
[62] | Fukui T, Watanabe D, Tamada Y, et al. Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget′s disease[J]. Acta Derm Venereol, 2009,89(2):150⁃154. doi: 10.2340/00015555⁃0623. |
[63] | Nakamura Y, Tanese K, Hirai I, et al. Weekly docetaxel monotherapy for metastatic extramammary Paget′s disease: retrospective single⁃institute analysis[J]. J Dermatol, 2020,47(4):418⁃422. doi: 10.1111/1346⁃8138.15255. |
[64] | Fukuda K, Hirai I, Nakamura Y, et al. S⁃1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget′s disease[J]. Eur J Dermatol, 2020,30(3):301⁃302. doi: 10.1684/ejd.2020.3782. |
[65] | Matsushita S, Fujii K, Kajihara I, et al. Efficacy of S⁃1 plus docetaxel in the treatment of metastatic extramammary Paget′s disease: a multicentre retrospective study[J]. Br J Dermatol, 2021,185(2):458⁃460. doi: 10.1111/bjd.20135. |
[66] | Tokuda Y, Arakura F, Uhara H. Combination chemotherapy of low⁃dose 5⁃fluorouracil and cisplatin for advanced extramammary Paget′s disease[J]. Int J Clin Oncol, 2015,20(1):194⁃197. doi: 10.1007/s10147⁃014⁃0686⁃2. |
[67] | Oashi K, Tsutsumida A, Namikawa K, et al. Combination chemotherapy for metastatic extramammary Paget disease[J]. Br J Dermatol, 2014,170(6):1354⁃1357. doi: 10.1111/bjd.12788. |
[68] | Angelico G, Santoro A, Inzani F, et al. Hormonal environment and HER2 status in extra⁃mammary Paget′s disease (eMPD): a systematic literature review and meta⁃analysis with clinical considerations[J]. Diagnostics (Basel), 2020,10(12):1040. doi: 10.3390/diagnostics10121040. |
[69] | Fukuda K, Funakoshi T. Metastatic extramammary Paget′s disease: pathogenesis and novel therapeutic approach[J]. Front Oncol, 2018,8:38. doi: 10.3389/fonc.2018.00038. |
[70] | Sekiguchi N, Kubota S, Noguchi T, et al. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2⁃positive extramammary Paget′s disease: four cases and a review[J]. J Dermatol, 2020,47(11):1276⁃1279. doi: 10.1111/1346⁃8138.15515. |
[71] | Mauzo SH, Tetzlaff MT, Milton DR, et al. Expression of PD⁃1 and PD⁃L1 in extramammary Paget disease: implications for immune⁃targeted therapy[J]. Cancers (Basel), 2019,11(6):754. doi: 10.3390/cancers11060754. |
[72] | Guercio BJ, Iyer G, Kidwai WZ, et al. Treatment of metastatic extramammary Paget disease with combination ipilimumab and nivolumab: a case report[J]. Case Rep Oncol, 2021,14(1):430⁃438. doi: 10.1159/000514345. |
[1] | Chinese Society of Dermatology, China Dermatologist Association, Chinese Association of Integrative Medicine Board of Dermatovenereology. Expert consensus on the clinical application of chemical peeling in China (2024 public version) [J]. Chinese Journal of Dermatology, 2024, 0(5): 20230620-e20230620. |
[2] | Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434. |
[3] | China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement (2024) [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417. |
[4] | Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection (2024) [J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208. |
[5] | China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, State Key Laboratory of Complex Severe and Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Expert consensus on the application and management of therapeutic drugs for atopic dermatitis (2024) [J]. Chinese Journal of Dermatology, 2024, 57(2): 97-108. |
[6] | Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China (2024) [J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118. |
[7] | Skin Cancer Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Melanoma Society of China Anti-Cancer Association. Expert consensus on human interferon α1b for the treatment of melanoma (2024) [J]. Chinese Journal of Dermatology, 2024, 57(1): 1-7. |
[8] | China Dermatologist Association. Guidance on application of moisturizers and emollients: an expert consensus (2023) [J]. Chinese Journal of Dermatology, 2023, 56(8): 711-717. |
[9] | Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang. Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023)” based on the Delphi method [J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539. |
[10] | Immunology Group, Chinese Society of Dermatology. Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023) [J]. Chinese Journal of Dermatology, 2023, 56(6): 479-488. |
[11] | Writing Committee Expert Group on “Treatment of mycosis fungoides: a Chinese expert consensus ()”. Treatment of mycosis fungoides: a Chinese expert consensus (2023) [J]. Chinese Journal of Dermatology, 2023, 56(5): 402-409. |
[12] | Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104. |
[13] | Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association . Expert consensus on the diagnosis and treatment of chronic actinic dermatitis (2023) [J]. Chinese Journal of Dermatology, 2023, 56(12): 1096-1106. |
[14] | Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology. Expert consensus on clinical application of wet-wrap therapy for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 289-294. |
[15] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
|